Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, April 5, 2011

2011 EASL; Easy To Understand Summary of the investigational Hepatitis C drugs



The International Liver Congress™ 2011 by EASL (46th annual meeting)

On The Website:
Summary of investigational Hepatitis C drugs presented at this months EASL;

On The Blog:
Daily meeting updates and press releases, click here

No comments:

Post a Comment